Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/veno-occlusive-disease-in-a-male-patient-with-marfan-syndrome-and-0sRZGIxh5B
References (28)
-
J. Bastie, F. Suzan, I. Garcia, F. Isnard, T. Revel, C. Terré, D. Mayeur, C. Abraham, R. Lavielle, S. Castaigne (2002)
Veno-occlusive disease after an anti-CD33 therapy (gemtuzumab ozogamicin).British Journal of Haematology, 116
-
M. Abecasis, JP Silva, I. Ferreira, A. Guimarães, A. Machado (1999)
Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantationBone Marrow Transplantation, 23
-
S. Kulkarni, M. Rodríguez, A. Lafuente, P. Mateos, J. Mehta, S. Singhal, R. Saso, D. Tait, J. Treleaven, R. Powles (1999)
Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD)Bone Marrow Transplantation, 23
-
J. Essell, M. Schroeder, G. Harman, R. Halvorson, Vernon Lew, N. Callander, M. Snyder, Stacey Lewis, J. Allerton, J. Thompson (1998)
Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow TransplantationAnnals of Internal Medicine, 128
-
E. Carreras, H. Bertz, W. Arcese, J. Vernant, José Tomas, Hans Hagglund, G. Bandini, H. Esperou, J. Russell, J. Rubia, G. Girolamo, H. Demuynck, O. Hartmann, J. Clausen, T. Ruutu, V. Leblond, A. Iriondo, A. Bosi, I. Ben-bassat, V. Koza, A. Gratwohl, J. Apperley (1998)
Incidence and Outcome of Hepatic Veno-Occlusive Disease After Blood or Marrow Transplantation: A Prospective Cohort Study of the European Group for Blood and Marrow TransplantationBlood, 92
-
S. Bearman, G. Anderson, M. Mori, M. Hinds, H. Shulman, G. McDonald (1993)
Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 11 9
-
P. Czauderna, K. Kątski, J. Kowalczyk, A. Kurylak, B. Lopatka, G. Skotnicka-Klonowicz, K. Sawicz-Birkowska, J. Godzinski (2000)
Venoocclusive liver disease (VOD) as a complication of Wilms' tumour management in the series of consecutive 206 patients.European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 10 5
-
R. Waldhorn, R. Waldhorn, E. Tsou, Frederick Smith, D. Kerwin (1984)
Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.Medical and pediatric oncology, 12 6
-
P. Robinson, P. Booms (2001)
Human Genome and Diseases:¶The molecular pathogenesis of the Marfan syndromeCellular and Molecular Life Sciences CMLS, 58
-
P. Richardson, A. Elias, A. Krishnan, C. Wheeler, R. Nath, D. Hoppensteadt, Nancy Kinchla, D. Neuberg, E. Waller, J. Antin, R. Soiffer, J. Vredenburgh, M. Lill, A. Woolfrey, S. Bearman, M. Iacobelli, J. Fareed, E. Guinan (1998)
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.Blood, 92 3
-
S. Bearman (2000)
Veno-occlusive disease of the liverCurrent Opinion in Oncology, 12
-
A. Cohen, S. Luger, C. Sickles, P. Mangan, David Porter, S. Schuster, D. Tsai, S. Nasta, A. Gewirtz, E. Stadtmauer (2002)
Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive diseaseBone Marrow Transplantation, 30
-
P. Craft, R. Pembrey (1987)
Veno-occlusive disease of the liver following chemotherapy with mitomycin C and doxorubicin.Australian and New Zealand journal of medicine, 17 4
-
J. Vansteenkiste, P. Bomans, E. Verbeken, K. Nackaerts, M. Demedts (2001)
Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.Lung cancer, 31 1
-
R. Chopra, J. Eaton, A. Grassi, M. Potter, B. Shaw, C. Salat, P. Neumeister, G. Finazzi, M. Iacobelli, K. Bowyer, H. Prentice, T. Barbui (2000)
Defibrotide for the treatment of hepatic veno‐occlusive disease: results of the European compassionate‐use studyBritish Journal of Haematology, 111
-
G. Bisogno, J. Kraker, A. Weirich, L. Masiero, R. Ludwig, M. Tournade, M. Carli (1997)
Veno-occlusive disease of the liver in children treated for Wilms tumor.Medical and pediatric oncology, 29 4
-
A. Paepe, R. Devereux, H. Dietz, R. Hennekam, R. Pyeritz (1996)
Revised diagnostic criteria for the Marfan syndrome.American journal of medical genetics, 62 4
-
F. Giles, G. Garcia-Manero, S. O'brien, E. Estey, H. Kantarjian (2002)
Fatal Hepatic Veno-Occlusive Disease in a Phase I Study of Mylotarg and Troxatyl in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeActa Haematologica, 108
-
Jill Smith, T. Riley, A. Devenyi, S. Bingaman, A. Kunselman (2004)
A Randomized Double-blind Placebo-controlled Trial -
D. Tack, L. Letendre, PS Kamath, A. Tefferi (2001)
Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemiaBone Marrow Transplantation, 28
-
S. Bearman (1995)
The syndrome of hepatic veno-occlusive disease after marrow transplantation.Blood, 85 11
-
G. McDonald, M. Hinds, L. Fisher, Howard Schoch, J. Wolford, M. Banaji, Barbara Hardin, H. Shulman, R. Clift (1993)
Veno-occlusive Disease of the Liver and Multiorgan Failure after Bone Marrow Transplantation: A Cohort Study of 355 PatientsAnnals of Internal Medicine, 118
-
G. McDonald, Pankaj Sharma, David Matthews, H. Shulman, E. Thomas (1984)
Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing FactorsHepatology, 4
-
F. Giles, H. Kantarjian, S. Kornblau, D. Thomas, G. Garcia-Manero, T. Waddelow, C. David, A. Phan, D. Colburn, A. Rashid, E. Estey (2001)
Mylotarg™ (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantationCancer, 92
-
H. Shulman, L. Fisher, H. Schoch, K. Henne, G. McDonald (1994)
Venoocclusive disease of the liver after marrow transplantation: Histological correlates of clinical signs and symptomsHepatology, 19
-
Richard Jones, Kamthorn Lee, W. Beschorner, V. Vogel, L. Grochow, H. Braine, G. Vogelsang, L. Sensenbrenner, G. Santos, R. Saral (1987)
VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATIONTransplantation, 44
-
J. Ortega, S. Donaldson, S. Ivy, A. Pappo, H. Maurer (1997)
Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcomaCancer, 79
-
D. Green, P. Norkool, N. Breslow, J. Finklestein, G. D'angio (1990)
Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 8 9
- Publisher
- Springer Journals
- Copyright
- Copyright © 2003 by Springer-Verlag
- Subject
- Medicine
- ISSN
- 0939-5555
- eISSN
- 1432-0584
- DOI
- 10.1007/s00277-003-0669-2
- pmid
- 12761649
- Publisher site
- See Article on Publisher Site
Abstract
Veno-occlusive disease (VOD) of the liver is characterized by jaundice, painful hepatomegaly, and retention of fluids. VOD is a severe complication in allogeneic stem cell or bone marrow transplantation. Additionally, the disease has been described in children suffering from nephroblastoma or rhabdomyosarcoma, treated with intense chemotherapy. Recently, VOD has been shown to be a complication in the treatment of myeloid leukemia with anti-CD33 linked to calicheamicin. We report the unusual case of a 21-year-old male patient with Marfan syndrome, diagnosed of acute lymphoblastic leukemia, who developed severe VOD during induction therapy after a single application of 2 mg vincristine. We speculate that coincidence of Marfan syndrome and application of induction chemotherapy might favor the disease in our patient.
Journal
Annals of Hematology – Springer Journals
Published: Jul 1, 2003